Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Non-interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients With CD30 Positive Lymphoma in China (REALM)

NCT05506774 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05506774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05506774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Non-interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients With CD30 Positive Lymphoma in China (REALM)
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
February 28, 2023
Completion date
July 3, 2024
Enrollment
1,006 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma